Publication
Lentivirally Delivered Glial Cell Line-Derived Neurotrophic Factor Increases the Number of Striatal Dopaminergic Neurons in Primate Models of Nigrostriatal Degeneration
Downloadable Content
- Persistent URL
- Last modified
- 05/21/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2002-06-15
- Publisher
- Lippincott, Williams & Wilkins
- Publication Version
- Copyright Statement
- Copyright © 2002 Society for Neuroscience
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 0888-0395
- Volume
- 22
- Issue
- 12
- Start Page
- 4942
- End Page
- 4954
- Grant/Funding Information
- This work was supported by a grant from the Department of Defense; a grant from the Parkinson's Foundation of the National Capital Area; and the Charles and M. V. Shapiro Foundation
- Abstract
- The primate striatum contains tyrosine hydroxylase (TH)-immunoreactive (ir) neurons, the numbers of which are augmented after dopamine depletion. Glial cell line-derived neurotrophic factor (GDNF) strongly modulates the viability and phenotypic expression of dopamine ventral mesencephalic neurons. The effect of GDNF on TH-ir neurons intrinsic to the striatum has yet to be investigated. In the present study, stereological counts of TH-ir striatal neurons in aged and parkinsonian nonhuman primates revealed that GDNF delivered via a lentiviral vector (lenti-) further increased the number of these cells. Aged monkeys treated with lenti-GDNF displayed an eightfold increase in TH-ir neurons relative to lenti-β-galactosidase-treated monkeys. Unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment alone in young monkeys resulted in a bilateral eightfold increase in TH-ir striatal cells. This effect was further magnified sevenfold on the side of lenti-GDNF treatment. These cells colocalized with the neuronal marker neuronal-specific nuclear protein. Some of these cells colocalized with GDNF-ir, indicating that an alteration in phenotype may occur by the direct actions of this trophic factor. Thus, GDNF may mediate plasticity in the dopamine-depleted primate brain, which may serve to compensate for cell loss by converting striatal neurons to a dopaminergic phenotype.
- Author Notes
- Keywords
- Animals
- Aging
- Neurons
- Lentivirus
- Tyrosine 3-Monooxygenase
- Fluorescent Antibody Technique
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Corpus Striatum
- Nerve Growth Factors
- Genetic Therapy
- Antiparkinson Agents
- Microscopy, Fluorescence
- Dopamine
- Nerve Tissue Proteins
- Genetic Vectors
- Cell Count
- Glial Cell Line-Derived Neurotrophic Factor
- Substantia Nigra
- Parkinson Disease
- Haplorhini
- Dopamine Agents
- Research Categories
- Health Sciences, Medicine and Surgery
- Biology, Neuroscience
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - v4n17.pdf | Primary Content | 2025-04-08 | Public | Download |